Summit Biolabs

The Saliva Diagnostics Expert

About Us

Summit Biolabs is harnessing the power of saliva-based diagnostics for COVID-19 and head & neck cancer.

An early-stage molecular diagnostics company, Summit Biolabs is pioneering early detection of head & neck cancer recurrence using a first of its kind saliva liquid-biopsy, HNKlear. HNKlear is a proprietary, non-invasive saliva test that provides more effective, more accurate, and earlier detection of head and neck cancer recurrence than traditional diagnostic methods. This novel approach has the potential to revolutionize head and neck cancer surveillance and improve patient outcomes.

Summit Biolabs is also leveraging its core competencies in saliva-based molecular diagnostics and viral nucleic acid detection to join the fight against COVID-19. Along with their clinical and laboratory partners, Summit Biolabs is developing the first comprehensive panel of highly-accurate saliva-based tests for COVID-19 infection, quantitation and immune response.

Leadership Team

Bob Blomquist
Chief Executive Officer

Shi-Long Lu, MD PhD
Profile: 16th Annual BioScience Colorado magazine (p.25)
President & Chief Scientific Officer, Founder

José Zevallos, MD MPH FACS
Chief Medical Officer

Brian L. Harry, MD PhD
Chief Laboratory Officer

Brian Williams, CPA
Chief Financial Officer

Eva Yao, PhD
Chief Operating Officer

Business Advisors

Stanley Lapidus
Serial Entrepreneur, Inventor, Educator

David Brunel
Serial Entrepreneur

Gilad Gordon, MD MBA
Expert on Clinical Trials for Drugs & Devices

Floyd Taub, MD
Serial Entrepreneur, Inventor

October 22, 2020
Summit Biolabs Commercializing Tests for Head and Neck Cancer Recurrence, COVID-19 ~ GenomeWeb Full Article
Link PDF

October 14, 2020
Summit, CCPM to Develop Saliva Tests for COVID, Head & Neck Cancer
Full Press Release

October 6, 2020
TiE Women of Denver "Walk n Talk" Interview of Summit
Event Announcement

October 2, 2020
Summit Biolabs Wins CBSA Innovation Forum 2020 Innovation Showcase Pitch Competition
Full Press Release

September 16, 2020
Summit Biolabs Selected to Receive Prestigious Investment from CDI Fund
Full Press Release

September 9, 2020
Summit Biolabs Selected to Present at the CBSA Innovation Forum on October 1, 2020
CBSA Innovation Forum 2020
LinkedIn Post

August 28, 2020
Summit Biolabs Wins TiE Women of Denver Virtual Pitch Competition 2020
Full Press Release
LinkedIn Post

Contact Us

Summit Biolabs, Inc.
12635 E. Montview Boulevard, Suite V-19
Aurora, Colorado 80045
USA

Thank You

We will get back to you shortly.